{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:49:43Z","timestamp":1790646583964,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,17]]},"DOI":"10.7759\/cureus.52467","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T05:44:07Z","timestamp":1705556647000},"source":"Crossref","is-referenced-by-count":8,"title":["Nonhormonal Pharmacotherapies for the Treatment of Postmenopausal Vasomotor Symptoms"],"prefix":"10.7759","author":[{"given":"Taylor","family":"Witten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Staszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory  A","family":"Granier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Lavespere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Dorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Allampalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2011.05.006","article-title":"Vasomotor symptoms and menopause: findings from the study of women's health across the nation","volume":"38","author":"Thurston RC","year":"2011","unstructured":"Thurston RC, Joffe H. Vasomotor symptoms and menopause: findings from the study of women's health across the nation. Obstet Gynecol Clin North Am. 2011, 38:489-501. 10.1016\/j.ogc.2011.05.006","journal-title":"Obstet Gynecol Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2021.17.2.133","article-title":"Contemporary non-hormonal therapies for the management of vasomotor symptoms associated with menopause: a literature review","volume":"17","author":"Sahni S","year":"2021","unstructured":"Sahni S, Lobo-Romero A, Smith T. Contemporary non-hormonal therapies for the management of vasomotor symptoms associated with menopause: a literature review. touchREV Endocrinol. 2021, 17:133-7. 10.17925\/EE.2021.17.2.133","journal-title":"touchREV Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001294","article-title":"Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17\u03b2-estradiol\/progesterone","volume":"26","author":"Mirkin S","year":"2019","unstructured":"Mirkin S, Graham S, Revicki DA, Bender RH, Bernick B, Constantine GD. Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17\u03b2-estradiol\/progesterone. Menopause. 2019, 26:637-42. 10.1097\/GME.0000000000001294","journal-title":"Menopause"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000320","article-title":"Incremental direct and indirect costs of untreated vasomotor symptoms","volume":"22","author":"Sarrel P","year":"2015","unstructured":"Sarrel P, Portman D, Lefebvre P, et al.. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause. 2015, 22:260-6. 10.1097\/GME.0000000000000320","journal-title":"Menopause"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0b013e31827d38a5","article-title":"Impact of the severity of vasomotor symptoms on health status, resource use, and productivity","volume":"20","author":"Whiteley J","year":"2013","unstructured":"Whiteley J, Wagner JS, Bushmakin A, Kopenhafer L, Dibonaventura M, Racketa J. Impact of the severity of vasomotor symptoms on health status, resource use, and productivity. Menopause. 2013, 20:518-24. 10.1097\/GME.0b013e31827d38a5","journal-title":"Menopause"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2019.909","article-title":"Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update","volume":"13","author":"Biglia N","year":"2019","unstructured":"Biglia N, Bounous VE, De Seta F, Lello S, Nappi RE, Paoletti AM. Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update. ecancer. 2019, 13:909. 10.3332\/ecancer.2019.909","journal-title":"ecancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-017-0487-7","article-title":"Obesity associates with vasomotor symptoms in postmenopause but with physical symptoms in perimenopause: a cross-sectional study","volume":"17","author":"Koo S","year":"2017","unstructured":"Koo S, Ahn Y, Lim JY, Cho J, Park HY. Obesity associates with vasomotor symptoms in postmenopause but with physical symptoms in perimenopause: a cross-sectional study. BMC Womens Health. 2017, 17:126. 10.1186\/s12905-017-0487-7","journal-title":"BMC Womens Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/10398562231165439","article-title":"Does menopause elevate the risk for developing depression and anxiety? Results from a systematic review","volume":"31","author":"Alblooshi S","year":"2023","unstructured":"Alblooshi S, Taylor M, Gill N. Does menopause elevate the risk for developing depression and anxiety? Results from a systematic review. Australas Psychiatry. 2023, 31:165-73. 10.1177\/10398562231165439","journal-title":"Australas Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-007-0209-5","article-title":"Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages","volume":"10","author":"Deecher DC","year":"2007","unstructured":"Deecher DC, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health. 2007, 10:247-57. 10.1007\/s00737-007-0209-5","journal-title":"Arch Womens Ment Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2013.08.010","article-title":"Menopausal hot flashes: mechanisms, endocrinology, treatment","volume":"142","author":"Freedman RR","year":"2014","unstructured":"Freedman RR. Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol. 2014, 142:115-20. 10.1016\/j.jsbmb.2013.08.010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2018.07.005","article-title":"Vasomotor symptoms across the menopause transition: differences among women","volume":"45","author":"Avis NE","year":"2018","unstructured":"Avis NE, Crawford SL, Green R. Vasomotor symptoms across the menopause transition: differences among women. Obstet Gynecol Clin North Am. 2018, 45:629-40. 10.1016\/j.ogc.2018.07.005","journal-title":"Obstet Gynecol Clin North Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1714787","article-title":"Hormone therapy for postmenopausal women","volume":"382","author":"Pinkerton JV","year":"2020","unstructured":"Pinkerton JV. Hormone therapy for postmenopausal women. N Engl J Med. 2020, 382:446-55. 10.1056\/NEJMcp1714787","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2022.09.006","article-title":"Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: a European cross-sectional survey","volume":"167","author":"Nappi RE","year":"2023","unstructured":"Nappi RE, Siddiqui E, Todorova L, Rea C, Gemmen E, Schultz NM. Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: a European cross-sectional survey. Maturitas. 2023, 167:66-74. 10.1016\/j.maturitas.2022.09.006","journal-title":"Maturitas"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1740","article-title":"Postmenopausal hormone therapy-local and systemic: a pharmacologic perspective","volume":"60","author":"Smith T","year":"2020","unstructured":"Smith T, Sahni S, Thacker HL. Postmenopausal hormone therapy-local and systemic: a pharmacologic perspective. J Clin Pharmacol. 2020, 60:S74-85. 10.1002\/jcph.1740","journal-title":"J Clin Pharmacol"},{"key":"ref15","unstructured":"Hormone therapy for menopause. (2023). Accessed. April 3, 2023: https:\/\/www.acog.org\/womens-health\/faqs\/hormone-therapy-for-menopause."},{"key":"ref16","article-title":"Hormone replacement therapy","author":"Harper-Harrison G","year":"2023","unstructured":"Harper-Harrison G, Shanahan MM. Hormone replacement therapy. StatPearls [Internet].  StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref17","unstructured":"Risk factors for cancer. hormones - NCI. (2015). Accessed: Accessed April 3, 2023: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/hormones."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55090573","article-title":"Current evidence of the oncological benefit-risk profile of hormone replacement therapy","volume":"55","author":"D'Alonzo M","year":"2019","unstructured":"D'Alonzo M, Bounous VE, Villa M, Biglia N. Current evidence of the oncological benefit-risk profile of hormone replacement therapy. Medicina (Kaunas). 2019, 55:573. 10.3390\/medicina55090573","journal-title":"Medicina (Kaunas)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6874-5-12","article-title":"An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology","volume":"5","author":"Rybaczyk LA","year":"2005","unstructured":"Rybaczyk LA, Bashaw MJ, Pathak DR, Moody SM, Gilders RM, Holzschu DL. An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Womens Health. 2005, 5:12. 10.1186\/1472-6874-5-12","journal-title":"BMC Womens Health"},{"key":"ref20","article-title":"Do SSRIs and SNRIs reduce the frequency and\/or severity of hot flashes in menopausal women","volume":"110","author":"Stubbs C","year":"2017","unstructured":"Stubbs C, Mattingly L, Crawford SA, Wickersham EA, Brockhaus JL, McCarthy LH. Do SSRIs and SNRIs reduce the frequency and\/or severity of hot flashes in menopausal women. J Okla State Med Assoc. 2017, 110:272-4.","journal-title":"J Okla State Med Assoc"},{"key":"ref21","unstructured":"Selective serotonin reuptake inhibitors (SSRIs) - Mayo Clinic. (2019). Accessed. Accessed April 3, 2023: https:\/\/www.mayoclinic.org\/diseases-conditions\/depression\/in-depth\/ssris\/art-20044825."},{"key":"ref22","article-title":"Selective serotonin reuptake inhibitors","author":"Chu A","year":"2023","unstructured":"Chu A, Wadhwa R. Selective serotonin reuptake inhibitors. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40688","article-title":"From antidepressant tianeptine to street drug ZaZa: a narrative review","volume":"15","author":"Wagner ML","year":"2023","unstructured":"Wagner ML, Pergolizzi J Jr, LeQuang JA, Breve F, Varrassi G. From antidepressant tianeptine to street drug ZaZa: a narrative review. Cureus. 2023, 15:e40688. 10.7759\/cureus.40688","journal-title":"Cureus"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e31826421a8","article-title":"Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial","volume":"20","author":"Pinkerton JV","year":"2013","unstructured":"Pinkerton JV, Constantine G, Hwang E, Cheng RF. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial. Menopause. 2013, 20:28-37. 10.1097\/gme.0b013e31826421a8","journal-title":"Menopause"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2019.1600501","article-title":"Managing vasomotor symptoms in women after cancer","volume":"22","author":"Pinkerton JV","year":"2019","unstructured":"Pinkerton JV, Santen RJ. Managing vasomotor symptoms in women after cancer. Climacteric. 2019, 22:544-52. 10.1080\/13697137.2019.1600501","journal-title":"Climacteric"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000000546","article-title":"Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society","volume":"22","year":"2015","unstructured":"Nonhormonal management of menopause-associated vasomotor symptoms. 2015 position statement of The North American Menopause Society. Menopause. 2015, 22:1155-74. 10.1097\/GME.0000000000000546","journal-title":"Menopause"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000386","article-title":"Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial","volume":"124","author":"Reed SD","year":"2014","unstructured":"Reed SD, Mitchell CM, Joffe H, et al.. Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial. Obstet Gynecol. 2014, 124:233-41. 10.1097\/AOG.0000000000000386","journal-title":"Obstet Gynecol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.4332","article-title":"Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes","volume":"38","author":"Ensrud KE","year":"2015","unstructured":"Ensrud KE, Guthrie KA, Hohensee C, et al.. Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes. Sleep. 2015, 38:97-108. 10.5665\/sleep.4332","journal-title":"Sleep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.1891","article-title":"Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial","volume":"174","author":"Joffe H","year":"2014","unstructured":"Joffe H, Guthrie KA, LaCroix AZ, et al.. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA Intern Med. 2014, 174:1058-66. 10.1001\/jamainternmed.2014.1891","journal-title":"JAMA Intern Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-1-124","article-title":"Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer","volume":"12","author":"Carpenter JS","year":"2007","unstructured":"Carpenter JS, Storniolo AM, Johns S, et al.. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist. 2007, 12:124-35. 10.1634\/theoncologist.12-1-124","journal-title":"Oncologist"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial","volume":"356","author":"Loprinzi CL","year":"2000","unstructured":"Loprinzi CL, Kugler JW, Sloan JA, et al.. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000, 356:2059-63. 10.1016\/S0140-6736(00)03403-6","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.1298","article-title":"Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial","volume":"29","author":"Boekhout AH","year":"2011","unstructured":"Boekhout AH, Vincent AD, Dalesio OB, et al.. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2011, 29:3862-8. 10.1200\/JCO.2010.33.1298","journal-title":"J Clin Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline","volume":"34","author":"Runowicz CD","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL, et al.. American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol. 2016, 34:611-35. 10.1200\/JCO.2015.64.3809","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/215621-nonhormonal-pharmacotherapies-for-the-treatment-of-postmenopausal-vasomotor-symptoms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:16:49Z","timestamp":1707509809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/215621-nonhormonal-pharmacotherapies-for-the-treatment-of-postmenopausal-vasomotor-symptoms"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.52467","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,17]]}}}